Log In
BCIQ
Print this Print this
 

Svac

  Manage Alerts
Collapse Summary General Information
Company Amarna Therapeutics B.V.
DescriptionNon-immunogenic SV40-based viral vector
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector
Latest Stage of DevelopmentPreclinical
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A and B
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/29/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today